Waters EBITDA Margin 2010-2023 | WAT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Waters (WAT) over the last 10 years. The current EBITDA margin for Waters as of December 31, 2023 is .
| Waters EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $2.96B | $0.98B | 33.24% |
| 2023-09-30 | $3.00B | $0.99B | 33.00% |
| 2023-06-30 | $2.99B | $0.99B | 32.93% |
| 2023-03-31 | $2.97B | $0.98B | 33.06% |
| 2022-12-31 | $2.97B | $1.00B | 33.77% |
| 2022-09-30 | $2.95B | $0.98B | 33.29% |
| 2022-06-30 | $2.90B | $0.98B | 33.90% |
| 2022-03-31 | $2.87B | $0.98B | 34.14% |
| 2021-12-31 | $2.79B | $0.95B | 34.24% |
| 2021-09-30 | $2.74B | $0.96B | 34.93% |
| 2021-06-30 | $2.67B | $0.92B | 34.43% |
| 2021-03-31 | $2.51B | $0.88B | 34.90% |
| 2020-12-31 | $2.37B | $0.77B | 32.54% |
| 2020-09-30 | $2.30B | $0.73B | 31.94% |
| 2020-06-30 | $2.28B | $0.74B | 32.66% |
| 2020-03-31 | $2.36B | $0.77B | 32.46% |
| 2019-12-31 | $2.41B | $0.81B | 33.83% |
| 2019-09-30 | $2.41B | $0.82B | 34.22% |
| 2019-06-30 | $2.41B | $0.82B | 34.16% |
| 2019-03-31 | $2.40B | $0.82B | 34.17% |
| 2018-12-31 | $2.42B | $0.85B | 35.04% |
| 2018-09-30 | $2.39B | $0.84B | 34.95% |
| 2018-06-30 | $2.38B | $0.82B | 34.54% |
| 2018-03-31 | $2.34B | $0.80B | 34.12% |
| 2017-12-31 | $2.31B | $0.77B | 33.26% |
| 2017-09-30 | $2.25B | $0.74B | 33.01% |
| 2017-06-30 | $2.21B | $0.73B | 33.18% |
| 2017-03-31 | $2.19B | $0.73B | 33.18% |
| 2016-12-31 | $2.17B | $0.72B | 33.26% |
| 2016-09-30 | $2.13B | $0.69B | 32.55% |
| 2016-06-30 | $2.10B | $0.67B | 32.10% |
| 2016-03-31 | $2.06B | $0.65B | 31.63% |
| 2015-12-31 | $2.04B | $0.66B | 32.21% |
| 2015-09-30 | $2.04B | $0.65B | 31.86% |
| 2015-06-30 | $2.03B | $0.66B | 32.48% |
| 2015-03-31 | $2.02B | $0.65B | 32.00% |
| 2014-12-31 | $1.99B | $0.61B | 30.75% |
| 2014-09-30 | $1.97B | $0.61B | 31.15% |
| 2014-06-30 | $1.94B | $0.59B | 30.28% |
| 2014-03-31 | $1.90B | $0.58B | 30.41% |
| 2013-12-31 | $1.90B | $0.60B | 31.42% |
| 2013-09-30 | $1.86B | $0.58B | 31.02% |
| 2013-06-30 | $1.85B | $0.58B | 31.25% |
| 2013-03-31 | $1.85B | $0.58B | 31.46% |
| 2012-12-31 | $1.84B | $0.58B | 31.47% |
| 2012-09-30 | $1.84B | $0.58B | 31.70% |
| 2012-06-30 | $1.85B | $0.59B | 31.73% |
| 2012-03-31 | $1.84B | $0.59B | 31.89% |
| 2011-12-31 | $1.85B | $0.60B | 32.13% |
| 2011-09-30 | $1.82B | $0.58B | 31.90% |
| 2011-06-30 | $1.76B | $0.55B | 31.46% |
| 2011-03-31 | $1.70B | $0.54B | 31.51% |
| 2010-12-31 | $1.64B | $0.51B | 31.14% |
| 2010-09-30 | $1.59B | $0.49B | 30.71% |
| 2010-06-30 | $1.56B | $0.48B | 30.67% |
| 2010-03-31 | $1.53B | $0.46B | 29.92% |
| 2009-12-31 | $1.50B | $0.45B | 30.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $18.401B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.398B | 26.71 |
| Intuitive Surgical (ISRG) | United States | $133.018B | 80.13 |
| DexCom (DXCM) | United States | $54.600B | 91.31 |
| Edwards Lifesciences (EW) | United States | $53.337B | 35.30 |
| IQVIA Holdings (IQV) | United States | $43.712B | 25.92 |
| IDEXX Laboratories (IDXX) | United States | $41.050B | 49.08 |
| Alcon (ALC) | Switzerland | $39.236B | 28.93 |
| STERIS (STE) | Ireland | $20.039B | 23.72 |
| Hologic (HOLX) | United States | $18.006B | 19.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.668B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.299B | 84.98 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.183B | 15.04 |
| Sysmex ADR (SSMXY) | Japan | $10.136B | 31.79 |
| Teleflex (TFX) | United States | $9.946B | 15.62 |
| Penumbra (PEN) | United States | $7.979B | 98.64 |
| Masimo (MASI) | United States | $7.192B | 40.33 |
| Globus Medical (GMED) | United States | $6.964B | 22.08 |
| Glaukos (GKOS) | United States | $5.066B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.130B | 26.40 |
| LivaNova (LIVN) | United Kingdom | $3.018B | 19.91 |
| TransMedics (TMDX) | United States | $2.908B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.697B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.654B | 18.21 |
| Nihon Kohden (NHNKY) | Japan | $2.411B | 20.40 |
| Integra LifeSciences Holdings (IART) | United States | $2.309B | 9.48 |
| Tandem Diabetes Care (TNDM) | United States | $2.267B | 0.00 |
| Inari Medical (NARI) | United States | $2.213B | 381.80 |
| RxSight (RXST) | United States | $1.954B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.758B | 0.00 |
| Veracyte (VCYT) | United States | $1.494B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.99 |
| Artivion (AORT) | United States | $0.862B | 99.62 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| Paragon 28 (FNA) | United States | $0.799B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.742B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.688B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.659B | 0.00 |
| SiBone (SIBN) | United States | $0.619B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.564B | 19.13 |
| IRadimed (IRMD) | United States | $0.537B | 31.21 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| Nevro (NVRO) | United States | $0.459B | 0.00 |
| NeuroPace (NPCE) | United States | $0.389B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.364B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.357B | 12.03 |
| CVRx (CVRX) | United States | $0.311B | 0.00 |
| AxoGen (AXGN) | United States | $0.300B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.278B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.254B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.235B | 0.00 |
| Accuray (ARAY) | United States | $0.218B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.188B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.187B | 10.08 |
| 908 Devices (MASS) | United States | $0.185B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.144B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.101B | 0.00 |
| Envoy Medical (COCH) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 109.33 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| DarioHealth (DRIO) | United States | $0.045B | 0.00 |
| InspireMD (NSPR) | Israel | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |